208 related articles for article (PubMed ID: 12531965)
1. Lack of chromosomal imbalances in adamantinomatous and papillary craniopharyngiomas.
Rickert CH; Paulus W
J Neurol Neurosurg Psychiatry; 2003 Feb; 74(2):260-1. PubMed ID: 12531965
[TBL] [Abstract][Full Text] [Related]
2. Comparative genomic hybridization analysis of craniopharyngiomas.
Rienstein S; Adams EF; Pilzer D; Goldring AA; Goldman B; Friedman E
J Neurosurg; 2003 Jan; 98(1):162-4. PubMed ID: 12546365
[TBL] [Abstract][Full Text] [Related]
3. Comparative genomic hybridization analysis of pediatric adamantinomatous craniopharyngiomas and a review of the literature.
Yoshimoto M; de Toledo SR; da Silva NS; Bayani J; Bertozzi AP; Stavale JN; Cavalheiro S; Andrade JA; Zielenska M; Squire JA
J Neurosurg; 2004 Aug; 101(1 Suppl):85-90. PubMed ID: 16206977
[TBL] [Abstract][Full Text] [Related]
4. Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma.
Kato K; Nakatani Y; Kanno H; Inayama Y; Ijiri R; Nagahara N; Miyake T; Tanaka M; Ito Y; Aida N; Tachibana K; Sekido K; Tanaka Y
J Pathol; 2004 Jul; 203(3):814-21. PubMed ID: 15221941
[TBL] [Abstract][Full Text] [Related]
5. Common mutations of beta-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region.
Buslei R; Nolde M; Hofmann B; Meissner S; Eyupoglu IY; Siebzehnrübl F; Hahnen E; Kreutzer J; Fahlbusch R
Acta Neuropathol; 2005 Jun; 109(6):589-97. PubMed ID: 15891929
[TBL] [Abstract][Full Text] [Related]
6. Genomic Alterations of Adamantinomatous and Papillary Craniopharyngioma.
Goschzik T; Gessi M; Dreschmann V; Gebhardt U; Wang L; Yamaguchi S; Wheeler DA; Lauriola L; Lau CC; Müller HL; Pietsch T
J Neuropathol Exp Neurol; 2017 Feb; 76(2):126-134. PubMed ID: 28069929
[TBL] [Abstract][Full Text] [Related]
7. Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome.
Weiner HL; Wisoff JH; Rosenberg ME; Kupersmith MJ; Cohen H; Zagzag D; Shiminski-Maher T; Flamm ES; Epstein FJ; Miller DC
Neurosurgery; 1994 Dec; 35(6):1001-10; discussion 1010-1. PubMed ID: 7885544
[TBL] [Abstract][Full Text] [Related]
8. Different keratin profiles in craniopharyngioma subtypes and ameloblastomas.
Tateyama H; Tada T; Okabe M; Takahashi E; Eimoto T
Pathol Res Pract; 2001; 197(11):735-42. PubMed ID: 11770017
[TBL] [Abstract][Full Text] [Related]
9. PROP1 and CTNNB1 expression in adamantinomatous craniopharyngiomas with or without β-catenin mutations.
Cani CM; Matushita H; Carvalho LR; Soares IC; Brito LP; Almeida MQ; Mendonça BB
Clinics (Sao Paulo); 2011; 66(11):1849-54. PubMed ID: 22086512
[TBL] [Abstract][Full Text] [Related]
10. Expression of aberrant beta-catenin and impaired p63 in craniopharyngiomas.
Cao J; Lin JP; Yang LX; Chen K; Huang ZS
Br J Neurosurg; 2010 Jun; 24(3):249-56. PubMed ID: 20128632
[TBL] [Abstract][Full Text] [Related]
11. Craniopharyngiomas of adamantinomatous type harbor beta-catenin gene mutations.
Sekine S; Shibata T; Kokubu A; Morishita Y; Noguchi M; Nakanishi Y; Sakamoto M; Hirohashi S
Am J Pathol; 2002 Dec; 161(6):1997-2001. PubMed ID: 12466115
[TBL] [Abstract][Full Text] [Related]
12. CTNNB1 gene mutations, pituitary transcription factors, and MicroRNA expression involvement in the pathogenesis of adamantinomatous craniopharyngiomas.
Campanini ML; Colli LM; Paixao BM; Cabral TP; Amaral FC; Machado HR; Neder LS; Saggioro F; Moreira AC; Antonini SR; de Castro M
Horm Cancer; 2010 Aug; 1(4):187-96. PubMed ID: 21761366
[TBL] [Abstract][Full Text] [Related]
13. Craniopharyngiomas express embryonic stem cell markers (SOX2, OCT4, KLF4, and SOX9) as pituitary stem cells but do not coexpress RET/GFRA3 receptors.
Garcia-Lavandeira M; Saez C; Diaz-Rodriguez E; Perez-Romero S; Senra A; Dieguez C; Japon MA; Alvarez CV
J Clin Endocrinol Metab; 2012 Jan; 97(1):E80-7. PubMed ID: 22031517
[TBL] [Abstract][Full Text] [Related]
14. MIB-1 immunoreactivity in craniopharyngiomas: a clinico-pathological analysis.
Duò D; Gasverde S; Benech F; Zenga F; Giordana MT
Clin Neuropathol; 2003; 22(5):229-34. PubMed ID: 14531547
[TBL] [Abstract][Full Text] [Related]
15. The pathogenesis of craniopharyngiomas.
Prabhu VC; Brown HG
Childs Nerv Syst; 2005 Aug; 21(8-9):622-7. PubMed ID: 15965669
[TBL] [Abstract][Full Text] [Related]
16. Distinct patterns of primary and motile cilia in Rathke's cleft cysts and craniopharyngioma subtypes.
Coy S; Du Z; Sheu SH; Woo T; Rodriguez FJ; Kieran MW; Santagata S
Mod Pathol; 2016 Dec; 29(12):1446-1459. PubMed ID: 27562488
[TBL] [Abstract][Full Text] [Related]
17. Clonal composition of human adamantinomatous craniopharyngiomas and somatic mutation analyses of the patched (PTCH), Gsalpha and Gi2alpha genes.
Sarubi JC; Bei H; Adams EF; Boson WL; Friedman E; Brandão K; Kalapothakis E; Miranda D; Valle FL; Sarquis MS; De Marco L
Neurosci Lett; 2001 Sep; 310(1):5-8. PubMed ID: 11524144
[TBL] [Abstract][Full Text] [Related]
18. Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas.
Brastianos PK; Taylor-Weiner A; Manley PE; Jones RT; Dias-Santagata D; Thorner AR; Lawrence MS; Rodriguez FJ; Bernardo LA; Schubert L; Sunkavalli A; Shillingford N; Calicchio ML; Lidov HG; Taha H; Martinez-Lage M; Santi M; Storm PB; Lee JY; Palmer JN; Adappa ND; Scott RM; Dunn IF; Laws ER; Stewart C; Ligon KL; Hoang MP; Van Hummelen P; Hahn WC; Louis DN; Resnick AC; Kieran MW; Getz G; Santagata S
Nat Genet; 2014 Feb; 46(2):161-5. PubMed ID: 24413733
[TBL] [Abstract][Full Text] [Related]
19. Study of β-catenin and BRAF alterations in adamantinomatous and papillary craniopharyngiomas: mutation analysis with immunohistochemical correlation in 54 cases.
Malgulwar PB; Nambirajan A; Pathak P; Faruq M; Suri V; Sarkar C; Jagdevan A; Sharma BS; Sharma MC
J Neurooncol; 2017 Jul; 133(3):487-495. PubMed ID: 28500561
[TBL] [Abstract][Full Text] [Related]
20. Monitoring the expression profiles of integrins and adhesion/growth-regulatory galectins in adamantinomatous craniopharyngiomas: their ability to regulate tumor adhesiveness to surrounding tissue and their contribution to prognosis.
Lefranc F; Mijatovic T; Decaestecker C; Kaltner H; André S; Brotchi J; Salmon I; Gabius HJ; Kiss R
Neurosurgery; 2005 Apr; 56(4):763-76. PubMed ID: 15792515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
